Kinome-Wide siRNA Screening Identifies SRC-Enhanced Resistance of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2018.01285
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

FZD7 in Triple Negative Breast Cancer Cells

2011English

Cisplatin Loaded Multiwalled Carbon Nanotubes Induce Resistance in Triple Negative Breast Cancer Cells

Pharmaceutics
Pharmaceutical Science
2018English

Triple-Negative Breast Cancer

2018English

TMEPAI Genome Editing in Triple Negative Breast Cancer Cells

Medical Journal of Indonesia
Medicine
2017English

Silencing the Roadblocks to Effective Triple-Negative Breast Cancer Treatments by siRNA Nanoparticles

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2017English

Apoptotic Resistance of Metastatic Tumor Cells in Triple Negative Breast Cancer: Roles of Death Receptor-5

Asian Pacific Journal of Cancer Prevention
2019English

Triple Negative Breast Cancer: Breast Cancer Research in Evolution

Breast Disease
MedicineCancer ResearchOncology
2011English

Cytotoxicity of Selenium Immunoconjugates Against Triple Negative Breast Cancer Cells

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

Dasatinib Sensitises Triple Negative Breast Cancer Cells to Chemotherapy by Targeting Breast Cancer Stem Cells

British Journal of Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy